Angiotensin II: a hormone that affects lipid metabolism in adipose tissue

被引:47
作者
Goossens, G. H.
Blaak, E. E.
Arner, P.
Saris, W. H. M.
Van Baak, M. A.
机构
[1] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, NL-6200 MD Maastricht, Netherlands
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden
关键词
angiotensin II; Ang II type 1 receptor; lipolysis; adipose tissue;
D O I
10.1038/sj.ijo.0803388
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Alterations in adipose tissue lipolysis may contribute to the pathophysiology of obesity and insulin resistance. We examined the effects of angiotensin II (Ang II) on abdominal subcutaneous adipose tissue lipolysis in humans. Methods and results: First, adipocytes obtained from nine normal weight and seven obese subjects were stimulated with Ang II (10(-14) - 10(-6) M). Glycerol concentration in the medium, used as an indicator of adipocyte lipolysis, was significantly reduced (similar to 20%) after Ang II stimulation in adipocytes from normal weight (P = 0.04) and obese subjects (P < 0.001). Based on these observations, adipocytes of seven additional obese subjects were stimulated with lower doses of Ang II (10(-17) - 10(-6) M) in the presence and absence of Ang II type 1 (AT(1)) receptor blockade. Lipolysis was dose dependently inhibited by similar to 20 to 25% after Ang II stimulation (P = 0.001). AT(1) receptor blockade completely abolished the Ang II-induced effects (P = 0.35). Conclusion: Ang II directly inhibits abdominal subcutaneous adipocyte lipolysis in normal weight and obese subjects via the AT1 receptor.
引用
收藏
页码:382 / 384
页数:3
相关论文
共 19 条
[1]
Insulin resistance in type 2 diabetes - Role of the adipokines [J].
Arner, P .
CURRENT MOLECULAR MEDICINE, 2005, 5 (03) :333-339
[2]
Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat [J].
Cabassi, A ;
Coghi, P ;
Govoni, P ;
Barouhiel, E ;
Speroni, E ;
Cavazzini, S ;
Cantoni, AM ;
Scandroglio, R ;
Fiaccadori, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2888-2897
[3]
SIMULTANEOUS RADIOIMMUNOASSAY OF 6 ANGIOTENSIN PEPTIDES IN ARTERIAL AND VENOUS PLASMA OF MAN [J].
CAMPBELL, DJ ;
KLADIS, A .
JOURNAL OF HYPERTENSION, 1990, 8 (02) :165-172
[4]
CRANDALL DL, 1994, J LIPID RES, V35, P1378
[5]
Goossens G H, 2003, Obes Rev, V4, P43
[6]
Angiotensin II-Induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects [J].
Goossens, GH ;
Blaak, EE ;
Saris, WHM ;
van Baak, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2690-2696
[7]
AUTOMATIC LUMINOMETRIC KINETIC ASSAY OF GLYCEROL FOR LIPOLYSIS STUDIES [J].
HELLMER, J ;
ARNER, P ;
LUNDIN, A .
ANALYTICAL BIOCHEMISTRY, 1989, 177 (01) :132-137
[8]
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors [J].
Janke, J ;
Engeli, S ;
Gorzelniak, K ;
Luft, FC ;
Sharma, AM .
DIABETES, 2002, 51 (06) :1699-1707
[9]
Impaired insulin action in subcutaneous adipocytes from women with visceral obesity [J].
Johnson, JA ;
Fried, SK ;
Pi-Sunyer, FX ;
Albu, JB .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (01) :E40-E49
[10]
Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells [J].
Jones, BH ;
Standridge, MK ;
Moustaid, N .
ENDOCRINOLOGY, 1997, 138 (04) :1512-1519